T-ALL

Clinical trials for T-ALL explained in plain language.

Never miss a new study

Get alerted when new T-ALL trials appear

Sign up with your email to follow new studies for T-ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Promising drug targets Tough-to-Treat leukemia in small trial

Disease control Recruiting now

This study tests a drug called isatuximab in 40 adults with a rare and aggressive blood cancer (T-cell acute lymphoblastic leukemia, or T-ALL) that has returned or not responded to standard treatment. The drug targets a protein (CD38) on the cancer cells to help the immune system…

Matched conditions: T-ALL

Phase: PHASE2 • Sponsor: Goethe University • Aim: Disease control

Last updated Apr 30, 2026 15:52 UTC

T-ALL

Get alerted when new T-ALL trials appear

Promising drug targets Tough-to-Treat leukemia in small trial